RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues
August 14, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Aug. 14, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced the issuance of a new patent (U.S. Patent Number 10,376,658) allowing the...
BioCardia Announces Issuance of European Patent for Breakthrough Diagnostic Assay for Patient Selection Prior to Cardiac Cell Therapy Delivery
August 08, 2019 08:30 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...
BioCardia Announces Closing of $10.0 Million Public Offering
August 06, 2019 16:05 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor
July 31, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
Former Johnson & Johnson Worldwide Director for Advanced Wound Care Joins RenovaCare
July 11, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., July 11, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds...
RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing
June 27, 2019 08:38 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ and other patented technologies for spraying a patient’s own...
Vice President to Expand RenovaCare SkinGun™ Technology for New Medical Conditions Beyond Burns
June 06, 2019 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., June 06, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) developer of patented technologies for spraying a patient’s own stem cells onto burns and...
Acute Myocardial Infarction Patients Treated Early With Cell Therapy Delivered With BioCardia’s Helix Endocardial Delivery System Improved in Ejection Fraction and NYHA Class
May 23, 2019 15:23 ET
|
BioCardia, Inc.
PARIS and SAN CARLOS, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
Cancer Stem Cell Therapeutics Market To Reach USD 16839 Million By 2026 | Reports And Data
May 20, 2019 13:30 ET
|
Reports And Data
NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding...
BioCardia Reports 2019 First Quarter Financial Results and Business Highlights
May 20, 2019 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported...